Introduction
============

The influence of sex on adipose tissue distribution and function, and its implication in metabolic syndrome has been known for a long time ([@ref-42]). The protective effects of estrogen on adipose tissue activity ([@ref-17]), and limitation of its hypertrophic growth ([@ref-36]) and inflammation ([@ref-59]) are key sex-related factors, which contribute to limit the disorders elicited by metabolic syndrome ([@ref-3]). The distribution of fat in gynoid and android shapes of adult humans is a consequence of the close interrelationship of adipose tissue with androgens and estrogens ([@ref-32]), modulated by their different response to glucocorticoids in the aftermath of a tissue defensive response against excess nutrient loads ([@ref-1]).

There are clear differences between females and males in site distribution and metabolic responses ([@ref-48]; [@ref-18]), but most studies on adipose tissue are limited to a single site or isolated cells, and are usually focused on the responses to inflammation ([@ref-52]).

The extensive metabolic capability of white adipose tissue (WAT) show a remarkable uniformity in metabolic function and overall regulation ([@ref-15]; [@ref-55]). As a consequence, the assumed main function of WAT (i.e., triacylglycerol storage as energy reserve) ([@ref-23]; [@ref-53]) is been reconsidered because of the multiple functions of this unique disperse organ ([@ref-21]; [@ref-22]; [@ref-26]). However, the level of knowledge of WAT metabolism, other than the control of lipid synthesis and storage, remains remarkably insufficient, constituting a handicap for interpretation of its physiological role ([@ref-31]).

WAT contains a complete urea cycle, as shown in the present study, which is, probably implicated in the extra-splanchnic production of citrulline, a critical factor for muscle function ([@ref-60]) and inter-organ 2-amino-N transport and utilization. However, WAT is also a massive producer of 3C fragments, such as lactate ([@ref-9]), but including alanine ([@ref-58]). WAT is also a net exporter of glutamine ([@ref-33]), and can use branched-chain amino acids for energy and lipogenesis ([@ref-29]). The large combined organ size, variety of known amino acid metabolic pathways and diverse physiological functions, hint at WAT as a potentially important site for peripheral amino acid metabolism. The information available is scant, we found only a couple of earlier studies ([@ref-39]; [@ref-34]); this is a serious limitation for a full understanding of whether amino acids should be also included in the well-established role of WAT in the management of energy, from glucose and lipids.

The little we know of WAT role in amino acid metabolism is further limited by our almost nil understanding of the role sex plays on WAT metabolism. In general terms, androgens favor protein deposition ([@ref-28]), and males tend to consume spontaneously more protein than females ([@ref-50]); on the other hand, estrogens lower body weight ([@ref-13]), in spite of females (women) having---normally---a higher body fat percentage than males (men). Young women are more resistant to obesity than men ([@ref-43]); however, after menopause, this estrogenic protection wanes ([@ref-14]).

In this study, we intended to determine whether the gross differences in WAT distribution and its resilience to change had a robust biochemical basis. Thus, we analyzed whether the WAT urea cycle and related amino acid catabolic processes of rats showed sex-modulated differences. To obtain a wider picture we studied the four main (largest) WAT sites in parallel, and we included in the analysis (for comparison) a number of gene expressions involved in the control of WAT lipogenesis from glucose and lipolysis.

Materials and Methods
=====================

Experimental design and animal handling
---------------------------------------

All animal handling procedures and the experimental setup were in accordance with the animal handling guidelines of the corresponding European and Catalan Authorities. The Committee on Animal Experimentation of the University of Barcelona specifically authorized the procedures used in the present study (DMAH-5483).

The experimental setup consisted on keeping two groups of undisturbed rats (female and male) under standard conditions for four weeks, in order to limit the influence of factors other than sex on the parameters analyzed.

Nine week old female and male Wistar rats (Harlan Laboratory Models, Sant Feliu de Codines, Spain) were used. The rats (*N* = 6 per group) were housed in pairs (same sex) in solid-bottom cages with wood shards for bedding. They had free access to water and ate normal rat chow (type 2014, Harlan). The rats were kept in a controlled environment (lights on from 08:00 to 20:00; 21.5--22.5 °C; 50--60% humidity) for one month.

The rats, without dietary manipulation, were killed, under isoflurane anesthesia, at the beginning of a light cycle (08:30--10:00), by aortic exsanguination, using dry-heparinized syringes; then, they were rapidly dissected, taking samples of WAT sites: mesenteric (ME), perigonadal (epididymal in males, periovaric in females, PG), retroperitoneal (RP) and subcutaneous (inguinal fat pads, SC). The samples were blotted and frozen with liquid nitrogen; after weighing, they were ground under liquid nitrogen and stored at −80 °C until processed. Later, the dissection of the rats continued, extracting the remaining WAT in ME, EP and RP sites; the rats were skinned, and the whole subcutaneous WAT was dissected. The weights of the recovered WAT were computed only to establish the total mass of each WAT site.

Blood plasma parameters
-----------------------

The blood obtained from the aorta was centrifuged to obtain plasma, which was frozen and kept at −80 °C until processed. Plasma samples were used to measure glucose (kit \#11504), triacylglycerols (kit \#11828), total cholesterol (kit \#11505) and urea (kit \# 11537), all from Biosystems, Barcelona Spain. Lactate was measured with another kit (ref. \#1001330; Spinreac, Sant Esteve de Bas, Spain). Amino acids were analysed individually using an amino acid analyser (Pharmacia-LKB-Alpha-plus, Uppsala, Sweden) from plasma samples deproteinized with acetone ([@ref-4]). Since the method used did not provide fair analyses for glutamine ([@ref-27]) and other amino acids (Trp, Cys, Asn), we decided to present only the partial sum of the other amino acids as a single indicative value.

Preparation of tissue homogenates
---------------------------------

Frozen tissue samples were homogenized, using a tissue disruptor (Ultraturrax IKA-T10, Ika Werke, Staufen, Germany), in 5 volumes of chilled 70 mM hepes buffer pH 7.4 containing 1 mM dithiothreitol (Sigma, St Louis MO USA), 50 mM KCl, 1 g/L Triton X-100 (Sigma) and 1 g/L lipid-free bovine serum albumin (Sigma). In homogenates to be used for carbamoyl-P synthase 2 estimation, the concentration of Triton X-100 was halved to decrease foaming. The homogenates were centrifuged for 10 min at 5,000 × g; the floating fat layers and gross debris precipitates were discarded. The clean homogenates were kept on ice, and used for enzymatic analyses within 2 h of their preparation.

Tissue protein content was estimated with the Lowry method ([@ref-40]). After development of color, fat droplet suspension-generated turbidity was eliminated with the addition of small amounts of finely powdered solid MgO before reading the absorbance. In the measurements of homogenate protein content, homogenization buffer (which contained albumin) was used as blank. Enzyme activities were expressed in nkat/g protein.

Enzyme activity analyses
------------------------

Carbamoyl-P synthase was estimated from the incorporation of ^14^C-bicarbonate (Perkin Elmer, Bad Neuheim, Germany) into carbamoyl-P using a method previously described by us ([@ref-8]). No significant carbamoyl-P synthase 1 activity was detected (and its gene was not expressed, either, in WAT). Thus, only carbamoyl-P synthase 2 was measured.

All other enzyme activities (ornithine carbamoyl-transferase, arginino-succinate synthase, arginino-succinate lyase and arginases 1 and 2) were estimated following recently developed methods, which are presented in detail in [Supplemental Information 1](#supp-1){ref-type="supplementary-material"} both to justify their adequacy and to allow others to employ a methodology developed for adipose tissue.

Gene expression analysis
------------------------

Total tissue RNA was extracted from frozen tissue samples using the Tripure reagent (Roche Applied Science, Indianapolis IN USA), and was quantified in a ND-100 spectrophotometer (Nanodrop Technologies, Wilmington DE USA). These data were also used to determine the total RNA content of the tissue (per g of tissue weight or g of protein) in order to establish comparisons between the quantitative importance of gene expressions. RNA samples were reverse transcribed using the MMLV reverse transcriptase (Promega, Madison, WI USA) system and oligo-dT primers.

Real-time PCR (RT-PCR) amplification was carried out using 10 µL amplification mixtures containing Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA USA), 4 ng of reverse-transcribed RNA and 150 nmol of primers. Reactions were run on an ABI PRISM 7900 HT detection system (Applied Biosystems) using a fluorescent threshold manually set to 0.15 for all runs.

A semi-quantitative approach for the estimation of the concentration of specific gene mRNAs per unit of tissue/RNA or protein weight was used ([@ref-54]). *Rplp0* was the charge control gene ([@ref-19]). We expressed the data primarily as the number of transcript copies per gram of protein in order to obtain comparable data between the groups. The genes analyzed and a list of primers used is presented in [Table 1](#table-1){ref-type="table"}.

10.7717/peerj.1399/table-1

###### Primer sequences used in the analysis of WAT gene expressions.

![](peerj-03-1399-g005)

          Protein                                                                  Gene      EC           Primer sequence 5′ \> 3′   Primer sequence 3′ \> 5′   bp
  ------- ------------------------------------------------------------------------ --------- ------------ -------------------------- -------------------------- -----
  CPS2    Glutamine-dependent carbamoyl-phosphate synthase                         *Cad*     6.3.5.5      AGTTGGAGGAGGAGGCTGAG       ATTGATGGACAGGTGCTGGT       90
  OTC     Ornithine carbamoyl transferase                                          *Otc*     2.1.3.3      CTTGGGCGTGAATGAAAGTC       ATTGGGATGGTTGCTTCCT        126
  ASS     Arginino-succinate synthase                                              *Ass1*    6.3.4.5      CAAAGATGGCACTACCCACA       GTTCTCCACGATGTCAATGC       100
  ASL     Arginino-succinate lyase                                                 *Asl*     4.3.2.1      CCGACCTTGCCTACTACCTG       GAGAGCCACCCCTTTCATCT       104
  ARG1    Arginase-1                                                               *Arg1*    3.5.3.1      GCAGAGACCCAGAAGAATGG       GTGAGCATCCACCCAAATG        126
  ARG2    Arginase-2                                                               *Arg2*    3.5.3.1      GCAGCCTCTTTCCTTTCTCA       CCACATCTCGTAAGCCAATG       122
  NAGS    N-acetyl-glutamate synthase                                              *Nags*    2.3.1.1      GCAGCCCACCAAAATCAT         CAGGTTCACATTGCTCAGGA       82
  eNOS    Nitric oxide synthase, endothelial                                       *Nos3*    1.14.13.39   CAAGTCCTCACCGCCTTTT        GACATCACCGCAGACAAACA       138
  GS      Glutamine synthetase                                                     *Glul*    6.3.1.2      AACCCTCACGCCAGCATA         CTGCGATGTTTTCCTCTCG        148
  Gase    Glutaminase kidney isoform, mitochondrial                                *Gls*     3.5.1.2      CCGAAGGTTTGCTCTGTCA        AGGGCTGTTCTGGAGTCGTA       63
  GDH1    Glutamate dehydrogenase 1, mitochondrial                                 *Glud1*   1.4.1.3      GGACAGAATATCGGGTGCAT       TCAGGTCCAATCCCAGGTTA       122
  GCS     Glycine cleavage system H protein, mitochondrial                         *Gcsh*    --           AAGCACGAATGGGTAACAGC       TCCAAAGCACCAAACTCCTC       146
  AMPD    AMP deaminase 2                                                          *Ampd2*   3.5.4.6      CGGCTTCTCTCACAAGGTG        CGGATGTCGTTACCCTCAG        78
  AlaT1   Alanine aminotransferase 1                                               *Gpt*     2.6.1.2      GTATTCCACGCAGCAGGAG        CACATAGCCACCACGAAACC       85
  AlaT2   Alanine aminotransferase 2                                               *Gpt2*    2.6.1.2      CATTCCCTCGGATTCTCATC       GCCTTCTCGCTGTCCAAA         146
  BCT1    Branched-chain-amino-acid aminotransferase, cytosolic                    *Bcat1*   2.6.1.42     TGCCCAGTTGCCAGTATTC        CAGTGTCCATTCGCTCTTGA       138
  BCT2    Branched-chain-amino-acid aminotransferase, mitochondrial                *Bcat2*   2.6.1.42     AGTCTTCGGCTCAGGCACT        ATGGTAGGAATGTGGAGTTGCT     84
  GLUT4   Solute carrier family 2 (facilitated glucose transporter), member 4      *Glut4*   --           CACAATGAACCAGGGGATGG       CTTGATGACGGTGGCTCTGC       127
  HK      Hexokinase-2                                                             *Hk2*     2.7.1.1      ATTCACCACGGCAACCACAT       GGACAAAGGGATTCAAGGCATC     113
  G6PDH   Glucose-6-phosphate 1-dehydrogenase                                      *G6pdx*   1.1.1.49     GACTGTGGGCAAGCTCCTCAA      GCTAGTGTGGCTATGGGCAGGT     77
  ME      NADP-dependent malic enzyme                                              *Me1*     1.1.1.40     TTCCTACGTGTTCCCTGGAG       GGCCTTCTTGCAGGTGTTTA       131
  PDHK2   Pyruvate dehydrogenase kinase 2, mitochondrial                           *Pdk2*    2.7.11.2     TCACTCTCCCTCCCATCAA        CGCCTCGGTCACTCATTT         75
  PDHK4   Pyruvate dehydrogenase \[acetyl transferring\] kinase 4, mitochondrial   *Pdk4*    2.7.11.2     GTCAGGCTATGGGACAGATGC      TTGGGATACACCAGTCATCAGC     137
  CATPL   ATP citrate lyase                                                        *Acly*    2.3.3.8      GACCAGAAGGGCGTGACCAT       GTTGTCCAGCATCCCACCAGT      96
  ACoAC   Acetyl-CoA carboxylase 1                                                 *Acaca*   6.4.1.2      AGGAAGATGGTGTCCGCTCTG      GGGGAGATGTGCTGGGTCAT       145
  FAS     Fatty acid synthase                                                      *Fasn*    2.3.1.85     CTTGGGTGCCGATTACAACC       GCCCTCCCGTACACTCACTC       163
  PCATl   Carnitine palmitoyltransferase 1, liver isoform                          *Cpt1a*   2.3.1.21     CCGCTCATGGTCAACAGCA        CAGCAGTATGGCGTGGATGG       105
  PCATm   Carnitine palmitoyltransferase 2, mitochondrial                          *Cpt2*    2.3.1.21     TGCTTGACGGATGTGGTTCC       GTGCTGGAGGTGGCTTTGGT       152
  ACADH   Long-chain acyl-CoA dehydrogenase, mitochondrial                         *Acadl*   1.3.8.8      ATGCCAAAAGGTCTGGGAGT       TCGACCAAAAAGAGGCTAATG      148
  ATL     Adipose triacylglycerol lipase                                           *Atgl*    3.1.1.3      CGGTGGATGAAGGAGCAGACA      TGGCACAGACGGCAGAGACT       138
  HSL     Hormone-sensitive lipase                                                 *Lipe*    3.1.1.79     CCCATAAGACCCCATTGCCTG      CTGCCTCAGACACACTCCTG       94
  LPL     Lipoprotein lipase                                                       *Lpl*     3.1.1.34     GAAGGGGCTTGGAGATGTGG       TGCCTTGCTGGGGTTTTCTT       103
          60S acidic ribosomal protein 0 (*housekeeping gene*)                     *Rplp0*   --           GAGCCAGCGAAGCCACACT        GATCAGCCCGAAGGAGAAGG       62

[Figure 1](#fig-1){ref-type="fig"} depicts a scheme of the relationships between the amino acid metabolism-related enzymes which gene expressions have been analyzed in this study. This Figure also shows acronyms or abbreviations of the names of the enzyme-genes used in [Figs. 2](#fig-2){ref-type="fig"} and [3](#fig-3){ref-type="fig"}.

![Scheme of the core of amino acid metabolism in WAT: urea cycle and ammonium handling.\
The abbreviations (marked in red) of the enzymes involved in the pathways depicted are the same described in [Table 1](#table-1){ref-type="table"} and throughout this study.](peerj-03-1399-g001){#fig-1}

Sex differences in gene expression
----------------------------------

The ample variability of cell volume, blood flow, innervation, size of fat deposits etc. of WAT poses additional problems for comparison between different anatomical (i.e., site), physiological (i.e., sex, diet) and pathological (i.e., obesity) situations ([@ref-16]; [@ref-49]; [@ref-25]). The variability of lipid reserves may convert in irrelevant comparisons based on weight; the use of DNA or cell number is a better approach, but the multiple types of cells coexisting in WAT (and their widely variable numbers) may also alter direct comparisons. We used as basic comparison the protein content, largely because it has been the choice reference for enzyme activity and, by extension to gene expressions and their possible interactions. However, probably a better way to measure changes in functional activity may be the analysis of mRNA production. These changes do not parallel those of weight, protein content or cell numbers, but are a fair index of the relative importance of translation of the genes involved with respect to total protein synthesis. In fact, their use is complementary of the analysis of enzyme activity-gene expression referred to protein weight, since it includes a new variable: metabolic transcendence for the cell of the synthesis of the corresponding mRNAs. We calculated the relationships of gene expressions to total tissue RNA (a crude approximation to mRNA) only to compare the specific effect of sex on a gene expression in a given site. Any significant deviation on the proportion of a gene expression with respect to the whole RNA mass may imply a differential modulation of this expression. We included these additional data to provide further insight into the ways and means of manifestation of sex-related differences.

Statistics
----------

Student's *t* test (unpaired) and two-way ANOVA comparisons between groups (using the post-hoc Tuckey test), correlations and curve fitting (including *V~i~* estimations) were analyzed with the Prism 5 program (GraphPad Software, San Diego CA USA). Data were presented as mean ± sem, and a limit of significance of *P* \< 0.05 was used throughout.

Results
=======

Basic parameters
----------------

[Table 2](#table-2){ref-type="table"} shows the body and main adipose tissue sites weights of undisturbed female and male animals. When aged 13 weeks, female rats weighed about 62% of their male counterparts. The males accumulated more fat than females, both in individual sites and as a whole. However, the sum of the four sites analyzed showed almost identical proportions *vs*. body weight, *c*. 8%. However, there were sex-related individual site differences in relative size expressed as percentage of body weight. There were also differences in total protein and RNA proportions (per g of fresh tissue) between the different sites, but there were no global effects attributable to the variable "sex".

10.7717/peerj.1399/table-2

###### Body and WAT site weight and composition of adult male and female Wistar rats.

The data correspond to the mean ± sem of 6 different animals. Statistical significance of the differences between groups was established with a 2-way anova; post-hoc Tuckey test: an asterisk \* represents *P* \< 0.05 differences between sex groups. Comparison of differences between the sums of sites was done using the Student's t test.

![](peerj-03-1399-g006)

  Parameter     Unit            Site          Male            Female        *p* site   *p* sex
  ------------- --------------- ------------- --------------- ------------- ---------- ----------
  Body weight   g               --            373 ± 6.1       232 ± 8.2     --         \<0.0001
  WAT weight    g               SC            12.2 ± 0.20\*   7.02 ± 0.25   \<0.0001   \<0.0001
  ME            4.94 ± 0.49\*   3.92 ± 0.33                                            
  PE            7.34 ± 0.64\*   4.83 ± 0.39                                            
  RE            6.29 ± 0.79\*   2.79 ± 0.35                                            
  Σ WAT         30.8 ± 1.7      18.6 ± 0.93   --              \<0.0001                 
  \% BW         SC              3.28 ± 0.05   3.04 ± 0.11     \<0.0001      NS         
  ME            1.33 ± 0.18     1.69 ± 0.13                                            
  PE            1.97 ± 0.13     2.10 ± 0.21                                            
  RE            1.69 ± 0.22     1.22 ± 0.17                                            
  Σ WAT         8.26 ± 0.47     8.05 ± 0.52   --              NS                       
  Protein       mg/g            SC            63.1 ± 11.6     51.8 ± 3.3    \<0.0001   NS
  ME            74.2 ± 7.4      84.2 ± 2.6                                             
  PE            44.3 ± 1.6      54.4 ± 2.4                                             
  RE            65.1 ± 6.3      62.9 ± 4.7                                             
  RNA           μg/g            SC            248 ± 51        219 ± 19      \<0.0001   NS
  ME            880 ± 84        793 ± 88                                               
  PE            94.3 ± 6.0      119 ± 10                                               
  RE            48.8 ± 4.1      78.4 ± 4.1                                             

**Notes.**

\% BWPercentage of body weight

The main plasma parameters studied are presented in [Table 3](#table-3){ref-type="table"}. Plasma glucose levels were higher in males than in females. However, these data were influenced by isoflurane anesthesia ([@ref-63]), and are presented only as a general indication of normalcy. No differences were observed for lactate and total cholesterol. Triacylglycerol levels were significantly higher in females (albeit in the limit of statistical significance). Both plasma urea and the partial sum of amino acids were also higher in female than in male rats.

10.7717/peerj.1399/table-3

###### Main energy plasma parameters of adult female and male Wistar rats.

The data correspond to the mean + sem of 6 different animals. Statistical significance of the differences between groups was established with the unpaired Student's *t* test.

![](peerj-03-1399-g007)

  Parameter                                      Units   Male           Female        *P* sex
  ---------------------------------------------- ------- -------------- ------------- ---------
  Glucose                                        mM      10.20 ± 0.42   8.64 ± 0.34   0.0169
  Lactate                                        mM      3.10 ± 0.29    3.78 ± 0.24   NS
  Total cholesterol                              mM      1.97 ± 0.07    1.98 ± 0.16   NS
  Triacylglycerols                               mM      1.50 ± 0.06    1.69 ± 0.06   0.0491
  Urea                                           mM      3.90 ± 0.17    5.13 ± 0.25   0.0029
  Amino acids[^a^](#table-3fn1){ref-type="fn"}   mM      3.34 ± 0.08    3.96 ± 0.18   0.0104

**Notes.**

This value does not include Gln, Asn, Trp and Cys.

Urea cycle enzymes
------------------

[Figure 2](#fig-2){ref-type="fig"} depicts urea-cycle enzyme activities and the expression of their corresponding genes in four main WAT sites of male and female rats. In both cases, activity and gene expression, the data were presented per g of tissue protein. The data are displayed on a log scale to allow a visual comparison of the site patterns of enzyme activities and expressions. The data used in this representation are also tabulated in numeric form in [Tables S1](#supp-1){ref-type="supplementary-material"} and [S2](#supp-1){ref-type="supplementary-material"}. There was a considerable coincidence in the patterns of enzyme activity distribution (and male--female similarities) in enzyme activities for all four sites. This pattern was not paralleled by that of the corresponding gene expression data, which also showed considerable uniformity in their patterns across the WAT sites. The statistical analysis of the data in [Fig. 2](#fig-2){ref-type="fig"} showed significant differences for "site" for all enzyme expressions except for arginino-succinate synthase. The site-related differences in enzyme activities, however, were limited to arginino-succinate lyase and carbamoyl-P synthase.

![Urea cycle enzyme activities and expressions of their coding genes in four WAT sites of female and male rats.\
All data are the mean ± sem of 6 animals, and are presented in a log scale. The numerical data are shown in [Tables S1](#supp-1){ref-type="supplementary-material"} and [S2](#supp-1){ref-type="supplementary-material"}. Panels in column (A): enzyme activities, red (intense colour) columns correspond to males and orange (light colour) corresponds to female rats. (B): gene expressions, blue (intense colour) columns represent the males, and green (light colour) represents the females. CPS2, carbamoyl-P synthase 2; OTC, ornithine carbamoyl-transferase; ASS, arginino-succinate synthase; ASL, arginino-succinate lyase; ARG, arginase. Statistical analysis (2-way anova) of the differences between groups. Activity: there were no significant differences for "sex"; CPS2 and ASL showed *P* \< 0.0001 for "site". Expression: only CPS2 showed a significant (*P* = 0.0002) for "sex": there were significant differences for "site" in CPS2 and ASL (*P* \< 0.0001), OTC (*P* = 0.0081), ARG1 + 2 (*P* \< 0.0001); ASS showed no significant differences. The application of post-hoc Tuckey test between male/female pairs are shown in the Figure as red stars.](peerj-03-1399-g002){#fig-2}

Subcutaneous WAT showed more differences between sexes than other locations, affecting carbamoyl-P synthase 2 (both activity and gene expression) and arginino-succinate lyase (only activity). Arginino-succinate synthase activity showed differences between females and males in mesenteric WAT, and its higher expression was observed in periovaric WAT.

Other amino acid metabolism-related gene expressions
----------------------------------------------------

[Figure 3](#fig-3){ref-type="fig"} shows the gene expressions of the non-urea cycle enzymes presented in [Fig. 1](#fig-1){ref-type="fig"}, as well as differentiated arginases 1 and 2, which were combined in [Fig. 2](#fig-2){ref-type="fig"}. The data are depicted also on a log scale to facilitate pattern comparison; the corresponding numerical results are shown in [Table S3](#supp-1){ref-type="supplementary-material"}.

![Expression of genes coding for enzymes of amino acid metabolism in WAT sites of male and female rats.\
All data are the mean ± sem of 6 animals, and are presented in a log scale. The numerical data are shown in [Table S3](#supp-1){ref-type="supplementary-material"}. Blue (dark colour) columns represent the males, and green (light colour) represents the females. NAGS, N-acetyl glutamate synthase; Ase1, arginase 1; Ase 2, Arginase 2; eNOS, endothelial nitric oxide synthase; GS, glutamine synthetase; Gase, glutaminase; GDH1, glutamate dehydrogenase (NADPH); AMPD, AMP deaminase; AlaT1, alanine transaminase 1; AlaT2, alanine transaminase 2; BCT1, branched-chain amino acid transaminase 1; BCT2, branched-chain amino acid transaminase 2. Statistical analysis (2-way anova) of the differences between groups. The variable "sex" showed global differences for Gase (*P* \< 0.0001), eNOS (*P* = 0.0014) and AlaT2 (*P* = 0.0018). The variable "site" showed significant differences for all genes (*P* \< 0.0001 for eNOS, Gase, GDH1, AMPD, BCT1 and AlaT2; *P* = 0.0005 for Ase1; *P* = 0.0014 for GS; *P* = 0.0023 for AlaT1, *P* = 0.024 for BCT2, and *P* = 0.039 for GCS) except N-acetyl-glutamate synthase. The application of post-hoc Tuckey test between male/female pairs are shown in the Figure as red stars between the corresponding columns.](peerj-03-1399-g003){#fig-3}

In all sites, the expression of e-NOS was, at least one order of magnitude higher than arginase; subcutaneous WAT being an exception: despite showing a similar pattern of expressions, the levels of mRNA per g of tissue protein were higher for most genes, in subcutaneous WAT, than in the other three sites. There was a generalized predominance of glutamine synthetase expression over that of glutaminase. The glycine cleavage system (specifically the H protein of the complex) and AMP deaminase showed also a robust expression, at levels comparable to those of alanine transaminases. The two branched-chain amino acid transaminases were also within this range, but the expression of the form 2 was much higher.

The statistical comparisons of the data in [Fig. 3](#fig-3){ref-type="fig"} present limited effects for sex; overall only nitric oxide synthase, alanine transaminase 2 and glutaminase showed significant overall differences between female and male rats. Paired sex-related differences were concentrated in subcutaneous WAT, with higher male values in the expression of nitric oxide synthase, glutamine synthase (but female-predominant glutaminase), AMP deaminase and alanine transaminase 1. No sex-related differences were found in the other sites, except higher male values in alanine transaminase 2 of perigonadal WAT. The differences between sites, however, were more marked, affecting all genes studied except N-acetyl-glutamate synthase (low expression) and arginase 2, which was expressed only in subcutaneous WAT.

Gene expressions of proteins involved in WAT acyl-glycerol metabolism
---------------------------------------------------------------------

[Figure 4](#fig-4){ref-type="fig"} presents the gene expressions of the key transporter and enzymes that regulate the lipogenic process from glucose to acetyl-CoA and from that metabolite to acyl-CoA, including the three most important WAT lipases. The data are presented in a log scale and the numerical data are shown in [Table S4](#supp-1){ref-type="supplementary-material"}. In spite of a considerable uniformity in the patterns for all four sites, there were marked differences in the extent of gene expression. In general, subcutaneous WAT values were higher, than those of the other sites. Again, overall (for mesenteric, retroperitoneal and perigonadal WAT), female expression values tended to be higher than those of the males for genes coding proteins favoring glucose incorporation (GLUT4, hexokinase), generation of NADPH (glucose-6P dehydrogenase, malic enzyme), and lipogenesis (citrate: ATP lyase, and acetyl-CoA carboxylase). Regulation of pyruvate dehydrogenase by its inhibiting kinases was higher in males, suggesting a lower mitochondrial availability of acetyl-CoA. In males, mitochondrial handling of fatty acids (carnitine palmitoleoyl-transferases, acyl-CoA dehydrogenases) and lipolysis (except adipose triacylglycerol lipase) showed higher relative expressions than in females.

![Expression of genes coding for transporter and enzymes related to lipogenesis from glucose and catabolism of lipid stores in WAT sites of male and female rats.\
All data are the mean ± sem of 6 animals, and are presented in a log scale. The numerical data are shown in [Table S4](#supp-1){ref-type="supplementary-material"}. Blue (dark colour) columns represent the males, and green (light colour) represents the females. GLUT4, glucose transpoirter 4; HK, hexokinase; G6PDH, glucose-6P dehydrogenase; ME, malic enzyme; PDHK2, pyruvate dehydrohenase kinase 2; PDHK4, pyruvate dehydrohenase kinase 4; CATPL, citrate: ATP lyase; AcCoAC, acetyl-CoA carboxylase; FAS, fatty acid synthase; PCATl, palmitoleoyl-carnitine acyl-transferase (liver); PCATm, palmitoleoyl-carnitine acyl-transferase (muscle); AcADH, acyl-CoA dehydrogenase; ATL, adipose triacylglycerol lipase; HSL, hormone-sensitive lipase; LPL, lipoprotein lipase. Statistical analysis (2-way anova) of the differences between groups. The variable "sex" showed global differences for HK (*P* = 0.0009), AcCoAC (*P* = 0.0035), GLUT4 (*P* = 0.0040), CATPL (*P* = 0.010), G6PDH (*P* = 0.020), PHDK4 (*P* = 0.020), ME (*P* = 0.024) and ATL (*P* = 0.026). The variable "site" showed significant differences for HSL, ATL and LPL (*P* \< 0.0001), PCATl (*P* = 0.0004), G6PDH (*P* = 0.0005), PDHK2 (*P* = 0.0013). PDHK4 (*P* = 0.0016), ACADH (0.0022), HK (*P* = 0.0057), PCATm (*P* = 0.015) and AcCoAC (*P* = 0.0384). The application of post-hoc Tuckey test between male/female pairs are shown in the Figure as red stars (*P* \< 0.05).](peerj-03-1399-g004){#fig-4}

Subcutaneous WAT showed higher expression values for males in pyruvate dehydrogenase kinase 4, palmitoleoyl.carnitine acyl-transferase (liver), acyl-CoA dehydrogenase and both lipoprotein and adipose triacylglycerol lipases. In mesenteric WAT, the only significant difference was for higher malic enzyme expression in females. In retroperitoneal WAT, female expression values were higher for malic enzyme, citrate: ATP lyase and acetyl-CoA carboxylase. Again, in perigonadal WAT, female expression values were higher for glucose-6P dehydrogenase. The overall differences for "site" were significant for all genes investigated except for GLUT4, malic enzyme, citrate: ATP lyase and fatty acid synthase.

Comparison of female and male gene expression
---------------------------------------------

[Table 4](#table-4){ref-type="table"} summarizes the sex-related differences in gene expression. The data are presented in two cooperative forms: expression per unit of protein and per unit of RNA weight in the tissue. The corresponding numerical data for RNA data and complete statistical analysis are shown on [Table S5](#supp-1){ref-type="supplementary-material"}. [Table 4](#table-4){ref-type="table"} shows only the cases where female--male differences were significant, and the genes are divided in four sections. In the first, corresponding to urea-cycle enzymes, only carbamoyl-P synthase 2 of subcutaneous WAT showed higher female than male values. No other differences were seen. There was a high degree of superimposition between the data obtained from protein and RNA; but the number of enzymes with statistically significant between sexes was higher in most WAT sites when the data of reference was RNA than when related to tissue protein.

10.7717/peerj.1399/table-4

###### Comparison of male-female specific expression of genes in different WAT sites with respect to tissue total protein or RNA.

The data are the mean ± sem of 6 animals per group, and are expressed as fmol of the corresponding gene mRNA per g of protein or mg of total RNA. The complete numerical data Table for RNA is presented in [Table S5](#supp-1){ref-type="supplementary-material"}. Only significant differences are shown. M \> F represents that male data were significantly higher than those of females; F \> M represented that female data were significantly higher than those of males. Analysis of significance was done using 1- and 2-way anovas (the latter for combined sites). The data in regular font correspond to significant values in the expression of fmol/mg RNA, those in italics correspond to the data which were significant only when expressed as fmol/g protein. The data in bold correspond to differences statistically significant both when referred to tissue protein and RNA.
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  Parameter                                                                          WAT site     All sites *P*                             
  ---------------------------------------------------------------------------------- ------------ --------------- ------------ ------------ ------------
  ***urea cycle enzymes***                                                                                                                  
  Carbamoyl-P synthase 2                                                             **F \> M**   --              --           --           *F\>M*
  Ornithine carbamoyl-transferase                                                    --           --              --           --           --
  Argininosuccinate synthase                                                         --           --              --           --           --
  Argininosuccinate lyase                                                            --           --              --           --           --
  Arginase 1                                                                         --           --              --           --           --
  ***other enzymes of amino acid metabolism***                                                                                              
  N-acetyl-glutamate synthase                                                        M\>F         --              --           --           --
  Glutamate dehydrogenase 1                                                          --           --              --           --           --
  Glutamine synthetase                                                               *M\>F*       --              --           --           M\>F
  Glutaminase                                                                        *F\>M*       F\>M            --           --           *F\>M*
  AMP deaminase                                                                      **M \> F**   --              --           --           M\>F
  Glycine cleavage system                                                            --           --              F\>M         --           --
  Alanine transaminase 1                                                             **M \> F**   --              --           M\>F         M\>F
  Alanine transaminase 2                                                             M\>F         --              **M \> F**   M\>F         **M \> F**
  Branched-chain amino acid transaminase 1                                           --           --              M\>F         M\>F         M\>F
  Branched-chain amino acid transaminase 2                                           --           --              --           --           --
  Endothelial nitric oxide synthase                                                  **M \> F**   --              --           M\>F         **M \> F**
  ***enzymes (and transporters) related with lipogenesis from glucose***                                                                    
  Glucose transporter 4                                                              --           --              --           F\>M         **F \> M**
  Hexokinase 2                                                                       --           --              F\>M         F\>M         **F \> M**
  Glucose-6P dehydrogenase                                                           --           F\>M            **F\>M**     F\>M         **F \> M**
  Malic enzyme                                                                       --           **F \> M**      F\>M         **F \> M**   **F \> M**
  Pyruvate dehydrogenase kinase 2                                                    M\>F         --              --           M\>F         M\>F
  Pyruvate dehydrogenase kinase 4                                                    **M \> F**   --              --           M\>F         **M \> F**
  Citrate: ATP lyase                                                                 --           F\>M            --           **F \> M**   **F \> M**
  Acetyl-CoA carboxylase                                                             F\>M         F\>M            --           **F \> M**   **F \> M**
  Fatty acid synthase                                                                --           F\>M            F\>M         F\>M         F\>M
  ***enzymes (and transporters) related with lipolysis and fatty acid oxidation***                                                          
  Carnitine palmitoleoyl transferase (liver)                                         **M \> F**   --              M\>F         M\>F         M\>F
  Carnitine palmitoleoyl transferase (muscle)                                        --           --              --           --           M\>F
  Long-chain acyl-CoA dehydrogenase                                                  **M \> F**   F\>M            --           --           M\>F
  Adipose tissue triacylglycerol lipase                                              **F \> F**   --              --           M\>F         **M \> F**
  Hormone-sensitive lipase                                                           --           --              --           --           M\>F
  Lipoprotein lipase                                                                 **M \> F**   --              --           M\>F         --

Other amino acid metabolism data showed a relative predominance of higher relative expressions in males, especially affecting the transaminases. The sites with more differences were subcutaneous and retroperitoneal WAT. In contrast, lipogenesis was more highly expressed in females, with minimal effects on subcutaneous and highest in retroperitoneal WAT. Male predominance was observed again on pyruvate dehydrogenase kinases' expressions, which increase marks a lower rate of production of acetyl-CoA as substrate for acyl-CoA synthesis. Finally, in the analysis of lipolytic and lipid oxidation-related genes, the male higher values were the norm, especially in subcutaneous and retroperitoneal WAT.

DISCUSSION
==========

The results presented support a wide extension of amino acid metabolism in different sites of WAT, with enzyme activities and expressions following similar patterns in all four sites studied. In addition to urea cycle, AMP-deaminase ([@ref-6]), glutamine synthetase ([@ref-7]), glutamate dehydrogenase ([@ref-5]) and nitric oxide synthase ([@ref-47]), we found that WAT expresses the glycine cleavage system (at least the H protein), so far not described.

The metabolic capabilities of WAT with respect to amino acid metabolism are probably more extensive than usually assumed ([@ref-2]), largely because it is unknown, with scant literature references to WAT amino acid metabolism ([@ref-39]; [@ref-34]; [@ref-29]; [@ref-37]). The range of expressions observed for amino acid metabolism-related enzymes in the four WAT sites studied ([Figs. 2](#fig-2){ref-type="fig"} and [3](#fig-3){ref-type="fig"}) was mostly in the 5--500 fmol/g protein. In comparison, the expressions ([Fig. 4](#fig-4){ref-type="fig"}) for lipogenesis, the (assumed) main metabolic function of WAT, and other lipid metabolism-related expressions were in the range of 10-1,000 fmol/g protein. Thus, the differences between lipogenesis and amino acid metabolism-related gene expressions were not as extensive as expected from the known massive mobilization/ deposition of triacylglycerols in adipocytes, compared with the relatively low level of cell proteins ([@ref-57]) (and cytoplasm) of WAT. This is compounded by the lack of sufficient data on WAT amino acid metabolism above indicated. The relatively elevated amino acid metabolism enzyme levels and gene expressions found hint at a potential relative importance of WAT on body amino acid metabolism.

The considerable uniformity of WAT urea cycle-enzyme activities and expressions, and their marked independence of sex can be interpreted essentially in two ways: (a) as playing a minimal metabolic role: i.e., a residual, secondary or specialized pathway. Or, alternatively, (b), it can be assumed to be a consequence of a well-established and robust homeostatic maintenance of its function. That is, a role critical enough not to be sensibly influenced by external regulatory factors such as sex hormones. The first possibility may seem the more obvious, but it is insufficient to counter a number of critical arguments: first of all, the unexpectedly high level of enzyme expressions and activities. Individual urea cycle enzymes are present in many tissues, [@ref-20], [@ref-44], and [@ref-51]. However, the mere existence of a complete urea cycle in a peripheral organ outside the splanchnic bed has not been previously described, as far as we know. A full operative urea cycle has been described only for liver ([@ref-20]). The key question is whether this cycle is functional or not. Due to its methodological difficulties, it should be studied using other (i.e., tracer) techniques. However, the relatively high enzyme activities and gene expressions observed, and the fact that all urea cycle and related ammonium metabolism enzymes are present suggest that this distribution has a clear functional purpose. This is, consequently, a situation different from that of tissues, which contain only part of the cycle to serve other metabolic purposes. The lack of sex-related differences in WAT sites of urea cycle compared with lipogenic processes, as shown in [Figs. 2](#fig-2){ref-type="fig"}--[4](#fig-4){ref-type="fig"} and the remarkable uniformity in pattern distribution between WAT sites also support the functionality of WAT urea cycle.

The varying ratios of activity/expression suggest a main post-translational control, extended to all sites. The high ornithine carbamoyl-transferase *vs*. arginino-succinate synthase activities suggest a probable implication in the peripheral (and critical) synthesis of citrulline ([@ref-62]), which may complement its conversion by the kidney ([@ref-11]). WAT participates in substrate cycles, including alanine synthesis ([@ref-58]) and glutamine release ([@ref-33]) in which amino acids are implicated. This analysis is further complicated by the quantitative importance of both activity and gene expressions compared with those of lipogenesis, the mainstay of WAT metabolism. Our understanding of these differences is complicated by the overall large size of the adipose organ ([@ref-55]), even taking into account the metabolically inert mass of fat. Taken together, these arguments support a significant role of WAT in amino acid metabolism.

Our data suggest, in any case, a clear site-sex interaction ([@ref-38]; [@ref-30]) that brings up differences in the expression of several amino acid metabolism-related genes other than urea cycle, which remains uncannily undisturbed and globally uniform. In males, subcutaneous WAT shows higher expressions for genes related to transfer of acyl-CoA to the mitochondria and its oxidation than females; this is consistent with the possibility of using fatty acids as energy substrate. The higher male inhibition of pyruvate dehydrogenase, by kinases, generalized to most sites, reinforces this trend. On the other side, the expression of WAT lipogenic enzyme genes (especially when expressed with respect to total RNA) was higher in females than in males. In contrast, lipases practically did not show differences. The different female-male specific metabolic predominance in WAT sites prove that the limited changes in urea cycle, compared with lipogenesis, could not be solely a consequence of overall lack of effects of sex on WAT; but it is, instead, a specific characteristic of WAT urea cycle as compared to other metabolic pathways.

The higher lipogenic (and lower lipolytic) gene expressions of female WAT is counterintuitive when we think of the higher WAT mass of adult male rats ([@ref-55]). Probably, the lower male gene expressions found here mirror a less active metabolism, in conjunction with the intestine and liver. The visceral fat accumulation in adult men ([@ref-12]) as compared with women is correlated with insulin resistance ([@ref-46]) and other metabolic syndrome-related pathologies ([@ref-61]). The discordances in sex-related control of metabolism and fat deposition between humans and rats are a critical caveat against generalization to humans of what is found using animal models, in spite of shared mechanisms and trends.

In addition to the human-rodent question, the main limitation of this study is the lack of previous data with which establish comparisons, made even more difficult by our scarce knowledge of amino acid metabolism. The extensive and interconnected net of pathways needs to be investigated. The most critical handicap, however, is the lack of a critical mass of scientists and of actualized methodology: specific protein measurement reagents (antibodies), and/or methods (and products) for the estimation of enzyme activities and metabolites of amino acid metabolism. Consequently, the data we present here should be taken as just an initial foray into a highly promising field of study.

An additional question may help explain the differences between sites ([@ref-38]; [@ref-56]), and the influence of sex (and sex hormones), the differences in cell populations of different WAT sites. A factor that affects the mean adipocyte size (also influenced by obesity ([@ref-24])) and the presence of other types of cells, in different proportions, such as macrophages ([@ref-35]), stem cells ([@ref-45]) and other stromal components ([@ref-41]).

Notwithstanding these caveats, the data gathered all point to a few preliminary conclusions, which could not be yet fully proven with the data we presented, largely because no other results are available for comparison or independent confirmation. The potential for lipid handling of WAT sites was strongly modulated by sex, being considerably dependent on the site studied. This part of the study, devised to provide a background comparison for amino acid metabolism showed more extensive differences than expected, and needs to be studied more specifically and deeply before sufficiently based conclusions could be extracted.

There was a considerable stability of the urea cycle activities and expressions, irrespective of sex, and with only limited influence of site. Which we interpret as this cycle operation being more general than the specialized site metabolic peculiarities, with robust control of WAT urea cycle, probably related to a possible role as provider of arginine/ citrulline ([@ref-10]). The resilience to change of urea cycle, in the context of a tissue characterized by its plastic adaptability, supports a generalized, probably essential, role in overall amino N handling.

In contrast, sex affected deeply WAT ammonium-centered amino N metabolism in a site-related fashion, with relatively higher levels of activity in males and in female subcutaneous WAT. The data on amino acid catabolism fit also with a role of mesenteric WAT as gatekeeper of the portal system, the hypothesis advanced for WAT glucose disposal ([@ref-9]) can be easily translated to the management of possible transient excesses of dietary amino acids.

In sum, WAT seems to play significant role in overall amino acid metabolism, including a functional urea cycle, which is not affected by sex. Contrary to lipid/glucose-related pathways, the data presented point to a centralized control of urea cycle operation affecting the adipose organ as a whole.
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